River Forest, IL, United States of America

Bruce Ronsen

This inventor holds 15 USPTO granted patents. Top assignees: Pentech Pharmaceuticals, Inc., 501 Greenwich Pharmaceuticals Incorporated, Greenwich Pharmaceuticals Incorporated. Active years: 1991-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce Ronsen. Retrieved from https://idiyas.com/inventor/bruce-ronsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 93.3

Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 317(Granted Patents)

Company Filing History:

13 out of 18

Pentech Pharmaceuticals, Inc.

patents

1 out of 1

501 Greenwich Pharmaceuticals Incorporated

patent

1 out of 8

Greenwich Pharmaceuticals Incorporated

patents

Years Active: 1991-2003

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6660298 - Paroxetine tablets and capsules (2003-12-09),

2. 6638948 - Amorphous paroxetine composition (2003-10-28),

3. 6566368 - Apomorphine-containing dosage form for ameliorating male erectile dysfunction (2003-05-20),

4. 6503927 - Amorphous paroxetine composition (2003-01-07),

5. 6306437 - Apomorphine-containing dosage forms for ameliorating male erectile dysfunction (2001-10-23),

6. 6193992 - Female sexual dysfunction treatment (2001-02-27),

7. 6121276 - Apomorphine-containing dosage forms for ameliorating male erectile (2000-09-19),

8. 5994363 - Amelioration of apomorphine adverse effects (1999-11-30),

9. 5945117 - Treatment of female sexual dysfunction (1999-08-31),

10. 5888534 - Controlled release of drugs delivered by sublingual or buccal (1999-03-30),

11. 5830500 - Low dose fluoxetine tablet (1998-11-03),

12. 5672612 - Amorphous paroxetine composition (1997-09-30),

13. 5624677 - Controlled release of drugs delivered by sublingual or buccal (1997-04-29),

14. 5010058 - 3,5,6-substituted derivatives of (1991-04-23),

15. 4996195 - Derivatives of .alpha.,D-glucofuranose or .alpha.,D-allofuranose and (1991-02-26),

Title: The Innovative Contributions of Bruce Ronsen

Introduction

Bruce Ronsen is a notable inventor based in River Forest, IL (US), recognized for his significant contributions to pharmaceutical formulations. With a total of 15 patents to his name, Ronsen has made strides in the development of therapeutic agents, particularly in the area of paroxetine.

Latest Patents

Ronsen's latest patents include innovative methods for preparing paroxetine tablets and capsules. One patent discloses a method for preparing a wet granule formulation of paroxetine hydrochloride, which is suitable for tabletting and capsulation. Another significant patent involves an amorphous paroxetine composition, which is a free-flowing, amorphous paroxetine hydrochloride composition. This composition is designed as a therapeutic agent for premature ejaculation and can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by drying. The resulting amorphous product is stable and substantially non-hygroscopic, making it a valuable addition to pharmaceutical formulations.

Career Highlights

Throughout his career, Ronsen has worked with reputable companies such as Pentech Pharmaceuticals, Inc. and 501 Greenwich Pharmaceuticals Incorporated. His work in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Ronsen has collaborated with several professionals in the field, including Ragab El-Rashidy and Emad Eldin Hassan. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Bruce Ronsen's innovative work in the pharmaceutical industry, particularly in the development of paroxetine formulations, showcases his dedication to improving therapeutic options. His contributions through patents and collaborations highlight his role as a significant inventor in the field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]